设为首页 加入收藏

TOP

GLIVEC Tablets (三十一)
2014-05-05 10:10:06 来源: 作者: 【 】 浏览:14304次 评论:0
served effect level (NOEL) was 30 mg/kg/day.
The mechanism and relevance of these findings in the rat carcinogenicity study for humans are not yet clarified.
Non-neoplastic lesions not identified in earlier preclinical studies were the cardiovascular system, pancreas, endocrine organs and teeth. The most important changes included cardiac hypertrophy and dilatation, leading to signs of cardiac insufficiency in some animals.
The active substance imatinib demonstrates an environmental risk for sediment organisms.
6. Pharmaceutical particulars
6.1 List of excipients
Tablet core:
Cellulose microcrystalline
Crospovidone
Hypromellose
Magnesium stearate
Silica, colloidal anhydrous
Tablet coat:
Iron oxide, red (E172)
Iron oxide, yellow (E172)
Macrogol
Talc
Hypromellose
6.2 Incompatibilities
Not applicable
6.3 Shelf life
3 years
6.4 Special precautions for storage
Do not store above 30°C.

Store in the original package in order to protect from moisture.
6.5 Nature and contents of container
 PVC/alu blisters

Glivec 100 mg film-coated tablets: Packs containing 20, 60, 120 or 180 film-coated tablets

Glivec 400 mg film-coated tablets: Packs containing 10, 30 or 90 film-coated tablets

Not all pack sizes may be marketed.
6.6 Special precautions for disposal and other handling
 Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
7. Marketing authorisation holder
 Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex, RH12 5AB

United Kingdom
8. Marketing authorisation number(s)
 Glivec 100 mg film-coated tablets:

EU/1/01/198/007

EU/1/01/198/008

EU/1/01/198/011

EU/1/01/198/012

Glivec 400 mg film-coated tablets:

EU/1/01/198/009

EU/1/01/198/010

EU/1/01/198/013
9. Date of first authorisation/renewal of the authorisation
 Date of first authorisation:
 07 November 2001
 
Date of latest renewal:
 07 November 2006
10. Date of revision of the text
 24 October 2013
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 28 29 30 31 下一页 尾页 31/31/31
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Cayston 75 mg powder and solven.. 下一篇Giotrif 40 mg film-coated table..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位